These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36104394)

  • 1. Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use.
    Kang YR; Kim JT; Lee JS; Kim BJ; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Park MS; Choi KH; Cho KH; Park JM; Lee SH; Lee J; Bae HJ
    Sci Rep; 2022 Sep; 12(1):15478. PubMed ID: 36104394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
    Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R
    Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
    Koton S; Molshatzki N; Bornstein NM; Tanne D
    Cerebrovasc Dis; 2012; 34(3):213-20. PubMed ID: 23006641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admission LDL-cholesterol, statin pretreatment and early outcomes in acute ischemic stroke.
    Kim JT; Lee JS; Kim BJ; Kang J; Lee KJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Lee K; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Yum KS; Sohn SI; Hong JH; Lee SH; Park MS; Choi KH; Lee J; Park KY; Bae HJ
    J Clin Lipidol; 2023; 17(5):612-621. PubMed ID: 37574400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prestroke statin use enhances collateralization in acute ischemic stroke patients.
    Zhu J; Ma M; Fang J; Bao J; Dong S; Chen N; Guo Y; He L
    Restor Neurol Neurosci; 2020; 38(4):311-321. PubMed ID: 32925118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; Luijckx GJ; De Keyser J
    J Neurol; 2008 Jun; 255(6):875-80. PubMed ID: 18338194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke.
    Rocco A; Sykora M; Ringleb P; Diedler J
    Cerebrovasc Dis; 2012; 33(4):362-8. PubMed ID: 22433177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prestroke statins use reduces oxidized low density lipoprotein levels and improves clinical outcomes in patients with atrial fibrillation related acute ischemic stroke.
    He L; Xu R; Wang J; Zhang L; Zhang L; Zhao W; Dong W
    BMC Neurol; 2019 Oct; 19(1):240. PubMed ID: 31627722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke.
    Scheitz JF; Seiffge DJ; Tütüncü S; Gensicke H; Audebert HJ; Bonati LH; Fiebach JB; Tränka C; Lyrer PA; Endres M; Engelter ST; Nolte CH
    Stroke; 2014 Feb; 45(2):509-14. PubMed ID: 24368561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic Thrombolysis.
    Mowla A; Shah H; Lail NS; Vaughn CB; Shirani P; Sawyer RN
    Cerebrovasc Dis; 2020; 49(5):503-508. PubMed ID: 32927457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration.
    Altersberger VL; Rusche N; Martinez-Majander N; Hametner C; Scheitz JF; Henon H; Dell'Acqua ML; Strambo D; Stolp J; Heldner MR; Grisendi I; Jovanovic DR; Bejot Y; Pezzini A; Leker RR; Kägi G; Wegener S; Cereda CW; Lindgren E; Ntaios G; Piot I; Polymeris AA; Lyrer PA; Räty S; Sibolt G; Tiainen M; Heyse M; Erdur H; Kaaouana O; Padjen V; Zedde M; Arnold M; Nederkoorn PJ; Michel P; Bigliardi G; Zini A; Cordonnier C; Nolte CH; Ringleb PA; Curtze S; Engelter ST; Gensicke H;
    Stroke; 2022 Dec; 53(12):3557-3563. PubMed ID: 36252105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with stroke treated with thrombolysis according to prestroke Rankin Scale scores.
    Gumbinger C; Ringleb P; Ippen F; Ungerer M; Reuter B; Bruder I; Daffertshofer M; Stock C;
    Neurology; 2019 Nov; 93(20):e1834-e1843. PubMed ID: 31653709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inpatient Statin Use Is Associated with Decreased Mortality of Acute Stroke Patients with Very Low Low-Density Lipoprotein Cholesterol.
    Song B; Wang Y; Zhao X; Liu L; Wang C; Wang A; Du W; Wang Y; Xu Y
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2369-74. PubMed ID: 26303789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion.
    Ricciardi AC; López-Cancio E; Pérez de la Ossa N; Sobrino T; Hernández-Pérez M; Gomis M; Munuera J; Muñoz L; Dorado L; Millán M; Dávalos A; Arenillas JF
    Cerebrovasc Dis; 2014; 37(4):304-11. PubMed ID: 24851928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and early outcomes after intravenous thrombolysis in acute ischemic stroke patients with prestroke disability.
    Cooray C; Karlinski M; Kobayashi A; Ringleb P; Kõrv J; Macleod MJ; Dixit A; Azevedo E; Bladin C; Ahmed N
    Int J Stroke; 2021 Aug; 16(6):710-718. PubMed ID: 32878588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial.
    Amarenco P; Kim JS; Labreuche J; Charles H; Giroud M; Lee BC; Lavallée PC; Mahagne MH; Meseguer E; Nighoghossian N; Steg PG; Vicaut É; Bruckert E;
    Stroke; 2022 Nov; 53(11):3260-3267. PubMed ID: 36154103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.
    Lee M; Cheng CY; Wu YL; Lee JD; Hsu CY; Ovbiagele B
    JAMA Neurol; 2022 Apr; 79(4):349-358. PubMed ID: 35188949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome.
    Tsai NW; Lee LH; Huang CR; Chang WN; Chang YT; Su YJ; Chiang YF; Wang HC; Cheng BC; Lin WC; Kung CT; Su CM; Lin YJ; Lu CH
    Crit Care; 2014 Jan; 18(1):R16. PubMed ID: 24423248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke.
    Meier N; Nedeltchev K; Brekenfeld C; Galimanis A; Fischer U; Findling O; Remonda L; Schroth G; Mattle HP; Arnold M
    Stroke; 2009 May; 40(5):1729-37. PubMed ID: 19265056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.